Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

Informations projet

NANOBIO4CAN

N° de convention de subvention: 101126492

DOI

10.3030/101126492

Date de signature de la CE 18 Septembre 2023

Date de début 1 Novembre 2023

Date de fin 31 Octobre 2028

Financé au titre de

• Marie Skłodowska-Curie Actions (MSCA)

Coût total

Aucune donnée

Contribution de l’UE

€ 2 292 480,00

Coordonné par

SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM
Türkiye

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Other (2)

Call 2 – Link to Euraxess website

Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Call 1 – Link to Euraxess website

Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Documents, reports (1)

Call 1 – Report on dissemination activities

Dates/Interval of call publication and dissemination channels/means (supporting documents are required as images, screen shots, photos from events).Flyers, brochures, or other information produced for dissemination of the callPresentations held at conferences and/or meetings and/or other eventsArticles published in the press (please list and attach only main articles)Any other means for advertising the programme

Publications

Conference proceedings (9)

DISSECTING TUMOR IMMUNE MICROENVIRONMENT IN HOSPITALIZED LUNG CANCER PATIENTS

Auteurs: Saif Ullah Afridi, Devrim Gözüaçık, Abdullah Karadağ
Éditeur: Gebze Technical University
DOI: 10.5281/ZENODO.20818489

Hyaluronic acid-functionalized CaCO₃ crystals as novel polyelectrolytemultilayer reservoirs for CPT-RB (Chemotherapy and Photodynamictherapy) targeting multiple myeloma

Auteurs: Nemany Hanafy, Safacan Kölemen
Éditeur: MDPI, The publisher of the Sciforum.net Platform
DOI: 10.5281/ZENODO.20818713

Synthesis and Engineering of Redox-Active NanoMOFs For PDT: A Step Towards Light-Triggered Cancer Therapeutics

Auteurs: Ankush Sontakke, Funda Acar Yağcı
Éditeur: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20817678

Photodynamic therapy combined with chemotherapy represents a novel strategy in multiple myeloma treatment: Nano-Multilayered strategy

Auteurs: A.N. Hanafy, Nemany, Kolemen, Safacan
Éditeur: Acıbadem Mehmet Ali Aydınlar University, In the framework of the International Day of Light 2026
DOI: 10.5281/ZENODO.21929621

Strain Development of Pichia Pastoris with Knockout of Calcium and Manganese Transporting ATPase (GDT1 and PMR1) Gene Through CRISPR-Cas9 Editing

Auteurs: Noor Hamizah Binti Suhaimi, Mehmet İnan
Éditeur: Zenodo
DOI: 10.5281/ZENODO.20818812

Functionalization of CaCO₃ crystals as novel polyelectrolyte multilayer reservoir for drug delivery

Auteurs: Nemany Hanafy, Safacan Kölemen
Éditeur: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20818077

REASSESSING THE ROLE OF ANTIGEN PROCESSING MACHINERY IN NEXTGENERATION PRECISION MEDICINE

Auteurs: Ika Nurlaila,Abdullah Karadağ
Éditeur: Gebze Technical University
DOI: 10.5281/ZENODO.20818120

Optimization of Soysaponin-Carbon Quantum Dots as Naturally Derived and Cost-Effective Theranostic CQDs for Targeted Imaging of Cancer Cells

Auteurs: Nemany Hanafy, Safacan Kölemen
Éditeur: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20818048

PB41 İN VİVO AKCİĞER TÜMÖR MİKROÇEVRESİNİ İNCELEMEK İÇİN TEKRARLANABİLİR YÖNTEM: ASPİRASYONLA OLUŞTURULAN ORTOTOPİK AKCİĞER KANSER MODELİ

Auteurs: Müge Özkan, Bilgi Güngör
Éditeur: XXVII. Ulusal İmmünoloji Kongresi
DOI: 10.5281/ZENODO.20818580

Other (1)

Molecular markers: BCL10

Auteurs: AFRIDI, SAIFULLAH, Karadag, Abdullah
Éditeur: PathologyOutlines.com
DOI: 10.5281/ZENODO.21470252

Peer reviewed articles (4)

Antibacterial Efficacy of Ti3C2Tx and Nb2CTx MXenes Against Gram-Positive and Gram-Negative Bacterial Strains

Auteurs: Mina Masoudi, Mina Namvari
Éditeur: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20817968

RSC Advances

Auteurs: Nemany A. N. Hanafy, Safacan Kolemen
Publié dans: RSC Advances, Numéro 16, 2026, ISSN 2046-2069
Éditeur: Royal Society of Chemistry
DOI: 10.1039/D5RA09823H

Spectral characterization and development of UV, direct fluorescence, and RP-HPLC-FLD assays for quantifying the BUB1 inhibitor BAY-1816032 in serum to support preclinical development

Auteurs: Fazel Gorjipour, Serif Senturk
Publié dans: Results in Chemistry, Numéro 29, 2026, ISSN 2211-7156
Éditeur: Elsevier BV
DOI: 10.1016/J.RECHEM.2026.103693

Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects

Auteurs: Kashif Maroof, Ronald Fook Seng Lee, Pinar Karacabey, Rükan Genç
Publié dans: ACS Pharmacology & Translational Science, Numéro 9, 2026, ISSN 2575-9108
Éditeur: American Chemical Society (ACS)
DOI: 10.1021/ACSPTSCI.5C00719